Skip to main content
The Canadian Veterinary Journal logoLink to The Canadian Veterinary Journal
letter
. 1983 Jun;24(6):200.

Preparation of Injectable Dantrolene for Emergency Treatment of Malignant Hyperthermia-like Syndromes

PJ O'Brien, GW Forsyth
PMCID: PMC1790375  PMID: 17422273

Full text

PDF

Page 200

200

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chalmers G. A., Barrett M. W. Capture myopathy in pronghorns in Alberta, Canada. J Am Vet Med Assoc. 1977 Nov 1;171(9):918–923. [PubMed] [Google Scholar]
  2. Glickman L. T., Appel M. J. Parvovirus infection and distemper vaccination. J Am Vet Med Assoc. 1981 May 15;178(10):1029–1031. [PubMed] [Google Scholar]
  3. Hall G. M. Dantrolene and the treatment of malignant hyperthermia. Br J Anaesth. 1980 Sep;52(9):847–849. doi: 10.1093/bja/52.9.847. [DOI] [PubMed] [Google Scholar]
  4. Harrison G. G. Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium. Br J Anaesth. 1975 Jan;47(1):62–65. doi: 10.1093/bja/47.1.62. [DOI] [PubMed] [Google Scholar]
  5. Kolb M. E., Horne M. L., Martz R. Dantrolene in human malignant hyperthermia. Anesthesiology. 1982 Apr;56(4):254–262. doi: 10.1097/00000542-198204000-00005. [DOI] [PubMed] [Google Scholar]
  6. Waldron-Mease E., Klein L. V., Rosenberg H., Leitch M. Malignant hyperthermia in a halothane-anesthetized horse. J Am Vet Med Assoc. 1981 Nov 1;179(9):896–898. [PubMed] [Google Scholar]

Articles from The Canadian Veterinary Journal are provided here courtesy of Canadian Veterinary Medical Association

RESOURCES